Literature DB >> 24247002

Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports.

Pavlina Kralickova1, Eva Mala, Doris Vokurkova, Irena Krcmova, Lenka Pliskova, Vlasta Stepanova, Vladimir Bartos, Vladimir Koblizek, Ilja Tacheci, Jan Bures, Jan Brozik, Jiri Litzman.   

Abstract

Common variable immunodeficiency (CVID) is the most frequent clinically relevant primary immunodeficiency and shows enormous heterogeneity in clinical presentation. Despite clinical immunodeficiency, opportunistic infections are not a typical manifestation of CVID. A retrospective study of 32 patients followed up for 335 patient-years was performed to determine the frequency of cytomegalovirus (CMV) disease. Symptomatic CMV infection was documented in 3 CVID patients. Patients No. 1 and 2 suffered from CMV pneumonia, with complications due to atypical mycobacteriosis in patient No. 1. Patient No. 3 suffered from CMV enteritis. A history of cancer and chronic hepatitis C infection (patient No. 1), immunosuppressive therapy for interstitial lung disease (patient No. 2) and serious enteropathy complicated with malnutrition (patient No. 3) may have contributed to the complications despite only mild abnormalities in T-cell subpopulations. The direct detection of CMV in bronchoalveolar lavage, stool or tissue samples was the most beneficial diagnostic laboratory method, whereas the detection of CMV DNA in blood did not produce positive results. Adequate treatment of CMV disease led to significant clinical improvement in all 3 patients. The frequency of CMV disease appears to be higher than previously described. In our experience, the probability of opportunistic infections in CVID patients increases with secondary comorbidities and their management.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247002     DOI: 10.1159/000355957

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  Common variable immunodeficiency syndrome with chronic diarrhoea.

Authors:  Mukesh Nasa; Smruti Ranjan Mishra; Lipika Lipi; Randhir Sud
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

3.  Neurologic Complications of Common Variable Immunodeficiency.

Authors:  Jenna Thuc-Uyen Nguyen; Ari Green; Michael R Wilson; Joseph L DeRisi; Katherine Gundling
Journal:  J Clin Immunol       Date:  2016-10-04       Impact factor: 8.317

Review 4.  Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).

Authors:  Mathieu Uzzan; Huaibin M Ko; Saurabh Mehandru; Charlotte Cunningham-Rundles
Journal:  Curr Gastroenterol Rep       Date:  2016-04

5.  Acute Gastrointestinal Bleeding Due to Cytomegalovirus Colitis in a Patient with Common Variable Immunodeficiency.

Authors:  Pradeep Kathi; Maher Tama; Vivek Reddy; Shankerdas Kundumadam; Omar Al-Subee; Murray N Ehrinpreis
Journal:  ACG Case Rep J       Date:  2018-05-23

6.  Cytomegalovirus Colitis in Primary Hypogammaglobulinemia With Normal CD4+ T Cells: Deficiency of CMV-Specific CD8+ T Cells.

Authors:  Sudhanshu Agrawal; Amrita Khokhar; Sudhir Gupta
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

7.  Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency.

Authors:  Samantha Chan; Jack Godsell; Miles Horton; Anthony Farchione; Lauren J Howson; Mai Margetts; Celina Jin; Josh Chatelier; Michelle Yong; Joseph Sasadeusz; Jo A Douglass; Charlotte A Slade; Vanessa L Bryant
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

8.  Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal Inflammation.

Authors:  Cornelia M van Schewick; David M Lowe; Siobhan O Burns; Sarita Workman; Andrew Symes; David Guzman; Fernando Moreira; Jennifer Watkins; Ian Clark; Bodo Grimbacher
Journal:  J Clin Immunol       Date:  2021-10-01       Impact factor: 8.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.